Marvin & Palmer Associates’s Gilead Sciences GILD Stock Holding History

Marvin & Palmer Associates’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,075	Closed	-$1.29M	–	46
2016 Q1	$1.29M	Sell	14,075 -10,800	-43%	-$974K	1.51%	32
2015 Q4	$2.52M	Sell	24,875 -800	-3%	-$83.2K	2.58%	16
2015 Q3	$2.52M	Sell	25,675 -3,425	-12%	-$380K	3.01%	11
2015 Q2	$3.41M	Sell	29,100 -200	-0.7%	-$21.9K	3.22%	7
2015 Q1	$2.88M	Buy	29,300 +3,040	+12%	+$309K	2.49%	14
2014 Q4	$2.48M	Buy	26,260 +3,440	+15%	+$356K	2.52%	9
2014 Q3	$2.43M	Buy	+22,820	New	+$2.23M	2.47%	10
2014 Q2	–	Sell	-23,155	Closed	-$1.64M	–	74
2014 Q1	$1.64M	Buy	23,155 +855	+4%	+$67.1K	1.44%	30
2013 Q4	$1.68M	Buy	22,300 +100	+0.5%	+$6.96K	1.01%	42
2013 Q3	$1.4M	Sell	22,200 -32,200	-59%	-$1.92M	0.91%	46
2013 Q2	$2.79M	Buy	+54,400	New	+$2.84M	1.51%	22

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marvin & Palmer Associates's GILD Position: Q2 2016 in Review

Marvin & Palmer Associates sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 14,075 shares — an estimated $1.29M sold.

Marvin & Palmer Associates first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $3.41M in Q2 2015. 1,599 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Marvin & Palmer Associates reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
Marvin & Palmer Associates sold 14,075 Gilead Sciences shares in Q2 2016, an estimated $1.29M.
Marvin & Palmer Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Marvin & Palmer Associates's Gilead Sciences position peaked at $3.41M in Q2 2015.
1,599 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Marvin & Palmer Associates's 13F filing for Q2 2016, filed 10 Aug 2016.